Cannabinoids and Their Receptors in Skin Diseases

    Eun Hee Yoo, Ji Hyun Lee
    New to cannabidiol? There is a guide in the encyclopedia. Read the guide →
    Studysummary This article highlights that while cannabinoids show potential for treating various skin conditions, current evidence is largely preclinical, with a need for comprehensive clinical trials to confirm these promising effects.
    Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
    The article "Cannabinoids and Their Receptors in Skin Diseases" examines the potential therapeutic benefits of cannabinoids like CBD and THC in treating skin conditions such as eczema, psoriasis, acne, pruritus, and skin cancer. Cannabinoids interact with CB1 and CB2 receptors to modulate inflammation, reduce cytokine production, and inhibit mast cell growth. Clinical trials have shown promising results, such as a 58.6% reduction in symptoms for 2,456 atopic dermatitis patients using PEA and significant improvements in psoriasis with 2.5% CBD ointment. Despite these positive findings, further research and large-scale clinical trials are needed to fully understand and optimize cannabinoid-based treatments for skin diseases.
    Discuss this study in the Community →

    Research cited in this study

    12 / 12 results